These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 29956426

  • 1. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
    Cunnama L, Abrams EJ, Myer L, Gachuhi A, Dlamini N, Hlophe T, Kikuvi J, Langwenya N, Mthethwa S, Mudonhi D, Nhlabatsi B, Nuwagaba-Biribonwoha H, Okello V, Sahabo R, Zerbe A, Sinanovic E.
    Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
    [Abstract] [Full Text] [Related]

  • 2. Provider- and patient-level costs associated with providing antiretroviral therapy during the postpartum phase to women living with HIV in South Africa: A cost comparison of three postpartum models of care.
    Cunnama L, Abrams EJ, Myer L, Phillips TK, Dugdale CM, Ciaranello AL, Zerbe A, Iyun V, MacQuilkan K, Daries V, Sinanovic E.
    Trop Med Int Health; 2020 Dec; 25(12):1553-1567. PubMed ID: 32959434
    [Abstract] [Full Text] [Related]

  • 3. Costs and Cost Drivers of Providing Option B+ Services to Mother-Baby Pairs for PMTCT of HIV in Health Centre IV Facilities in Jinja District, Uganda.
    Mukose AD, Kebede S, Muhumuza C, Makumbi F, Komakech H, Bayiga E, Busobozi D, Musinguzi J, Kuznik A, Stegman P, Forsythe S, Kagaayi J.
    Biomed Res Int; 2020 Dec; 2020():2875864. PubMed ID: 32550228
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS, Dokubo EK, Sint TT.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, Ghana.
    VanDeusen A, Paintsil E, Agyarko-Poku T, Long EF.
    BMC Infect Dis; 2015 Mar 18; 15():130. PubMed ID: 25887574
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV.
    O'Brien L, Shaffer N, Sangrujee N, Abimbola TO.
    Bull World Health Organ; 2014 Mar 01; 92(3):162-70. PubMed ID: 24700975
    [Abstract] [Full Text] [Related]

  • 15. Impact of universal antiretroviral therapy for pregnant and postpartum women on antiretroviral therapy uptake and retention.
    Abrams EJ, Langwenya N, Gachuhi A, Zerbe A, Nuwagaba-Biribonwoha H, Mthethwa-Hleta S, Sahabo R, Lesosky M, Okello V, Myer L.
    AIDS; 2019 Jan 27; 33(1):45-54. PubMed ID: 30289804
    [Abstract] [Full Text] [Related]

  • 16. Uptake of guidelines on prevention of mother-to-child transmission of HIV in rural Tanzania: time for change.
    Gamell A, Letang E, Jullu B, Mwaigomole G, Nyamtema A, Hatz C, Battegay M, Tanner M.
    Swiss Med Wkly; 2013 Jan 27; 143():w13775. PubMed ID: 23519621
    [Abstract] [Full Text] [Related]

  • 17. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    Kesho Bora Study Group, de Vincenzi I.
    Lancet Infect Dis; 2011 Mar 27; 11(3):171-80. PubMed ID: 21237718
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2013 Mar 01; 62(8):148-51. PubMed ID: 23446514
    [Abstract] [Full Text] [Related]

  • 20. Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding HIV-positive women initiating 'Option B+' in the South West Region.
    Atanga PN, Ndetan HT, Achidi EA, Meriki HD, Hoelscher M, Kroidl A.
    Trop Med Int Health; 2017 Feb 01; 22(2):161-170. PubMed ID: 27865052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.